--Bicycle announces publication of article on tumor-targeted immune cell agonists
--Genprex initiated with a Buy at National Securities 07:27 GNPX National Securities initiated coverage of Genprex with a Buy rating and $7 price target.
--Luminar downgraded to Market Perform from Outperform at Northland »
--Velodyne Lidar signs multi-year sales agreement with Emesent
--Boxlight price target raised to $5 from $4 at Alliance Global Partners 07:15 BOXL Alliance Global Partners analyst Brian Kinstlinger raised the firm's price target on Boxlight to $5 from $4 and reiterates a Buy rating on the shares. The analyst sees Boxlight as best positioned to benefit from growth trends in the interactive displays market given the acquisition of Sahara.
Beneficial owner of Barnwell Industries (BRN) Ned Sherwood purchased 233,545 shares of company stock at $1.75 per share for a total transaction value of $409,474
--Twitter bans MyPillow CEO on 'repeated violations' of policy, NY Times reports »
Ass Hole alert***** This guy is un American.
--Red Rock Resorts price target raised to $30 from $28 at Goldman Sachs 05:02 RRR Goldman Sachs analyst Stephen Grambling raised the firm's price target on Red Rock Resorts to $30 from $28 and keeps a Buy rating on the shares.
- Beneficial owner of Aldeyra Therapeutics (ALDX) Perceptive Advisors purchased 1,368,421 shares of company stock at $9.50 per share for a total transaction value of $13,000,000